Dear E,
Normally in January, the biopharma world would descend on San Francisco for the J.P. Morgan Healthcare Conference. Executives take over hotels and coffee shops, rub elbows, shake hands, and see the who's who of the biopharma world. But as we all know, that world is a long way away and virtual is our new reality.
One thing we have learned from 2020 is that the show must go on and the world must keep turning. We hope you will join us January 11-13, 2021 for a three-day virtual event that goes beyond the cutting-edge panel discussions we are known for. We bring you CEO interviews, news recaps, and panel discussions exploring biopharma's ongoing work to combat COVID-19 – and to fight the world's other diseases at the same time.
A sample of our planned schedule includes:
Panel Discussions:
- In-development COVID-19 therapeutics
- "Second-wave" COVID-19 vaccines
- The last mile: How will a COVID-19 vaccine make it from plant to patients?
Executive Interviews:
- Daphne Koller, CEO, insitro
- Vivian Lee, President of Health Platforms, Verily Life Sciences
- David Feinberg, M.D., Vice President of Google Health
- Tim Wentworth, CEO of Cigna's Evernorth
- And more...
We'll have a strong focus on networking this year and will facilitate one to one meetings and groups chats with speakers, partners and attendees. I hope you can join us. Click here to reserve your seat today.
 | Rebecca Willumson |